1 / 52

Meningitis

Meningitis. David A. Wilfret, MD Pediatric Infectious Diseases Duke University Medical Center. Meningitis. Meningitis – Inflammation of the membranes that surround the brain and spinal cord (the dura mater, archnoid mater, and pia mater) Encephalitis – Inflammation of the cerebral cortex

colm
Télécharger la présentation

Meningitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Meningitis David A. Wilfret, MD Pediatric Infectious Diseases Duke University Medical Center

  2. Meningitis • Meningitis – Inflammation of the membranes that surround the brain and spinal cord (the dura mater, archnoid mater, and pia mater) • Encephalitis – Inflammation of the cerebral cortex • Meningoencephalitis – Inflammation of the meninges and the cerebral cortex

  3. Pathogenesis • Bacteria • Maternal genital secretions or nasopharyngeal colonization • Mucosal invasion and penetration into the blood stream • Hematogenous spread through the BBB (choroid plexus) or direct inoculation • Virus • Upper respiratory tract or gastrointestinal tract • Primary viremia • Proliferation in other organs (lymph nodes, liver, spleen) • Secondary viremia through the BBB Chavez-Bueno S, Pediatr Clin N Am 52;795-810.

  4. Pathogenesis • Inflammation within the subarachnoid space • Cell wall or membrane components • Gram positive - Peptidoglycan • Gram negative - Lipopoly-saccharides • Inflammatory mediators • TNF-alpha, IL-1, IL-6, IL-8, IL-10, PAF, NO, prostaglandins, and macrophage induced proteins • Cerebral edema, increased ICP, and toxic oxygen radicals causing apoptosis Chavez-Bueno S. Pediatr Clin N Am 52;795-810.

  5. Neonatal Meningitis • Patient is a 3 wk old formerly full-term, vaginal delivery who presents to the ED • He has been irritable throughout the day with poor feeding throughout the day • One hour prior to arrival, he developed a rectal temperature of 100.6 F • In the ED he appears fussy and difficult to console, but otherwise stable • On physical examination he has a temperature of 101 F, a flat fontanelle, no nuchal rigidity, and no Kernig’s nor Brudzinski’s sign

  6. Neonatal Meningitis • Incidence 0.25 – 1 per 1000 live births • Risk factors • Perinatal and intrauterine infection (T > 100.4oC), prolonged rupture of membranes (> 18 hours), prematurity (< 37 wks), low birth weight, previous infant with GBS disease, maternal urinary tract infection • Early and late onset meningitis • Neonatal sepsis arises < 1 %, • Meningitis 25 % of septic neonates • One percent of lumbar punctures

  7. Clinical Manifestations - Neonate Signs and SymptomsIncidence (%) Temperature Instability 60 Fussy / Lethargy 60 Poor Feeding and Vomiting 48 Seizures 42 Respiratory Distress 33 Apnea 31 Bulging Fontanelle 25 Diarrhea 20 Nuchal Rigidity 13 Signs of meningitis are often subtle in the neonate Classic symptoms of meningitis not until 18 – 24 months

  8. What Laboratory Studies Would you Order? • CBC with Differential • Electrolytes and LFTs • Urinalysis • Cerebrospinal Fluid • WBC with Differential • RBC • Protein • Glucose • Gram-stain • Blood Culture • Urine Culture • CSF Culture • Viral Culture CSF and surfaces • HSV and Enterovirus PCR

  9. Laboratory Results • CBC: WBC 8000 cells/mm3, N 60% B 10% L 23%, H/H 11.2 / 30 and Platelets 150,000 • Electrolytes: CO2 18 and Glucose 80, LFTs normal • Urinalysis: Protein 1+, Ketones 1+, Nitrites neg, LE neg, WBC 1, RBC 0, Bacteria 0-5 • CSF: WBC 120, P 80% L 10% M 10%, RBC 5, Protein 240, Glucose 30 Is this consistent with meningitis?

  10. Cerebrospinal Fluid - Neonates

  11. Evaluated 9111 neonates > 34 weeks gestation to establish concordance of CSF culture, CSF parameters, and blood culture in culture-proven neonatal meningitis • Thirty-eight percent of neonates with culture-proven meningitis had a negative blood culture • Peripheral WBCs were neither sensitive nor specific for bacterial meningitis

  12. Due to the variability in CSF parameters, unable to develop an algorithm to accurately and precisely predict meningitis based on CSF parameters alone

  13. Ten percent of neonates with bacterial meningitis had < 3 CSF WBCs/mm3 A threshold value of 21 cells as the upper limit of normal would have missed 12.6% of meningitis cases Meningitis can occur in the presence of normal CSF WBC, protein, and glucose levels

  14. Culture Results • Gram Stain Gram-positive cocci in pairs / chains • CSF Culture Group B Streptococcus • Blood Culture Negative • Urine Culture Negative • Virus Culture, Cancelled after Gram-stain Positive and HSV and Enterovirus PCR

  15. What are the most Common Organisms that cause Bacterial Meningitis in Neonates? • Group B Streptococcus (30 – 40 %) • Gram-negative enteric bacilli (30 – 40 %) • Escherichia coli, Klebsiella, Enterobacter, Salmonella, Serratia marcesans, Citrobacter, and Proteus mirabilis • Listeria monocytogenes (10 %) • Others include Staphylococcus aureus, viridans streptococci, and coagulase-negative staphylococci

  16. What Antibiotics would you Empirically Start? Ampicillin Plus an Aminoglycoside Or Cefotaxime Infants (> 1 month) Vancomycin plus Cefotaxime

  17. Specific Therapy OrganismAntibioticDuration GBS Sensitive Penicillin or Ampicillin 14 – 21 days L. Monocytogenes Ampicillin plus Aminoglycoside 14 - 21 days Gram-Negative 3rd Cephalosporin 21 days Enteric Organisms plus Aminoglycoside 14 days after Negative Staphylococcus Sensitive Nafcillin or Oxacillin 21 days Resistant Vancomycin plus Rifampin

  18. Development Delay 26% Hydrocephalus 24% Ventriculitis 20% Late Seizure 19% Cerebral Palsy 17% Brain Abscess 13% Hearing Loss 12% Subdural Effusion 11% Cortical Blindness <10% Neonatal Complications Mortality 15 – 20 %

  19. Meningitis • Patient is a 4 year old Hispanic male without past medical history who presents to the ED • He complains of fevers (T 103.8 F), headaches, photophobia, neck stiffness, vomiting, myalgias, and drowsiness over the past 24 hours • On physical examination, he is febrile (T 102.4 F), but vitals are otherwise stable. He is alert and irritable, but able to cooperate with the examination. He is without focal neurologic signs and there is no rash.

  20. What would you look for on Physical Examination that is Specific for Meningitis? Nuchal Rigidity Kernig’s Sign Brudzinski’s Sign

  21. Kernig and Brudzinski’s Sign Kernig and Brudzinski’s sign present 5% of adults with meningitis Nuchal rigidity present in 30% of adults with meningitis

  22. What Laboratory Studies Would you Order? • CBC with Differential • Electrolytes and LFTs • Cerebrospinal Fluid • Opening Pressure • WBC with Differential • RBC • Protein • Glucose • Gram-stain • India Ink / Cryptococcal Antigen if Immuno-compromised • Blood Culture • CSF Culture • Viral Culture CSF, Nasopharyngeal, and Perirectal • Enterovirus PCR

  23. Would you Order a Head CT prior to the LP? • Head CT should be performed if signs of increased intracranial pressure on physical examination and should not result in delay of blood tests nor start of antibiotics • Abnormalities detected on CT scan were already suspected by neurological examination and did not effect clinical management Signs of Increased Intracranial Pressure focal neurologic signs, altered level of consciousness, bradycardia, hypertension or hypotension, and altered respiratory pattern (papilledema late sign) Cabral DA. J Pediatr 1987;111:201.

  24. Laboratory Results • CBC: WBC 21,000 cells/mm3, N 70% B 5% L 15%, H/H 14 / 36 and Platelets 470,000 • Electrolytes (Glucose 70) and LFTs Normal • CSF: Cloudy, WBC 1400, P 80% L 10% M 10%, RBC 120, Protein 180, Glucose 20

  25. Bacterial vs. Aseptic Meningitis • Bacterial Meningitis • Meningitis caused by identified bacteria • Peak in the Fall and Winter • Aseptic Meningitis • Meningitis not caused by identified bacteria • Most common type of meningitis • Peak in the late Spring to Fall • Biphasic fever (especially with enteroviruses)

  26. Cerebrospinal Fluid

  27. Cerebrospinal Fluid • Bacterial meningitis • WBCs >1000 cells/mm3 with neutrophil predominance > 80% • Early infection can have a lymphocyte predominance in 10% of patients with WBCs < 100 cells/mm3 then neutrophil predominance at 48 h • Neutrophil predominance related to bacterial meningitis but no threshold of clinical significance (N 90 % = PPV 25%) • Viral meningitis • WBC < 100 cells/mm3 with lymphocyte predominance • Early infection neutrophil predominance (59%) with WBCs >1000 cells/mm3 then lymphocyte predominance after 24 h • During the peak season for aseptic meningitis, a patient with neutrophil predominance is more likely to have aseptic meningitis than bacterial meningitis Negrini B. Pediatrics 2000;105:316.

  28. Culture Results • Gram Stain Gram-positive cocci in pairs / chains • CSF Culture Streptococcus pneumoniae • Blood Culture Streptococcus pneumoniae • Viral Cultures Negative and Enterovirus PCR

  29. Cerebrospinal Fluid • Gram-stain Sensitivity • S. pneumoniae 90% • H. influenzae 86% • N. meningitidis 75% • Gram-negative bacilli 50% • L. monocytogenes 33% • Specificity > 97% • Bacterial Culture • Sensitivity 70-85%

  30. Traumatic Tap CSF is Uninterpretable • CSF contaminated with blood in up to 20% of taps • Both underdiagnose and overdiagnose bacterial meningitis • Repeat lumbar puncture after 48 hours Rules 1 WBC/mm3 for every 500 – 1000 RBC/mm3 WBC (CSF) = WBC (CSF) – [WBC (Bld) x RBC (CSF)]/RBC (Bld) Bonsu BK. PIDJ 2006;25:8.

  31. Partially Treated Meningitis • Up to 50% of cases may initially receive oral antibiotics • CSF WBCs, protein, and glucose generally remain abnormal for at least 44 – 68 hours after antibiotics • CSF Sterilization • N. meningitidis within 1 – 2 hours • S. pneumoniae within 4 hours • Gram-stain sensitivity ~20% lower Feigen RD. Textbook of Pediatric Infectious Diseases 4th Ed. 1998. Kanegave JT, et al. Pediatrics 2001;108:1169.

  32. Partially Treated Meningitis • Latex agglutination • Detects bacterial capsular antigens, thus results are not affected by prior antibiotics • Low PPV and NPV - A positive or negative latex agglutination does not change clinical therapy or hospital course • Polymerase Chain Reaction • Enterovirus and Herpes Simplex Virus • Sensitivity and specificity > 90% • Presumed bacterial meningitis treat at least 10 days Hayden RT. PIDJ 2000;19:290-2 Tunkel AR. IDSA Guidelines Meningitis. CID 2004;39:1267.

  33. Of pretreated children, Gram-stain was positive in 60% and latex agglutination was positive in 42% • Latex agglutination test did not identify any pathogen that was not identified by blood or CSF culture • Of culture-negative, pretreated children, none were positive by latex agglutination • Negative latex agglutination test did not decrease the risk of bacterial meningitis Nigrovic LE, et al. PIDJ 2004;23:786.

  34. What are the most Common Organisms that cause Bacterial Meningitis in this Age Group? Streptococcus pneumoniae 4, 6B, 9, 14, 18F, 19F, 23F Neisseria meningitidis B, C, Y, W-135 Haemophilus influenzae type B

  35. Enteroviruses (Coxsackie and ECHO viruses) Arboviruses (St. Louis, Western and Eastern Equine, West Nile, California (Lacrosse) Viruses Herpes viruses Mumps Virus Human Immunodeficiency Virus LCMV Respiratory Viruses (Adenovirus, Rhinovirus, Influenza Virus, Parainfluenza Virus) Viral Meningitis Kumar R. Indian J Pediatr 2005;72:57.

  36. Bacteria Partially Treated M. tuberculosis M. pneumoniae C. pneumoniae Ehrlichiosis B. burgdorfi T. pallidum Brucella Leptospirosis Fungi C. neoformans H. capsulatum Coccidioides immitis Blatomyces dermatitides Candida Aseptic Meningitis - Infectious • Parasites • Toxoplasma gondii • Neurocysticercosis • Trinchinosis • Naeglaria • Bartonella henselae • Rickettsia • RMSF • Typhus Kumar R. Indian J Pediatr 2005;72:57.

  37. Postinfectious / Postvaccinial Drugs Systemic Diseases (Rheumatologic) Neoplastic Diseases Parameningeal Inflammation Aseptic Meningitis - Noninfectious Kumar R. Indian J Pediatr 2005;72:57.

  38. What antibiotics would you empirically start? Vancomycin Third-generation cephalosporin (Ceftriaxone or Cefotaxime)

  39. Definitive Meningitis: Positive CSF Gram-stain for bacteria Probable Meningitis: Age < 6 months and CSF WBC ≥100 and low glucose in CSF; or CSF WBC ≥ 500 or; CSF WBC elevated for age and >70% neutrophils or; CSF WBC elevated for age and localizing neurologic exam regardless of age or; CSF WBC elevated for age and one risk factor: Seizures Altered mental status Hypotension or hemodynamic instability Age < 12 months and not vaccinated Immunocompromised; e.g. sickle cell, IgG deficiency, HIV PICU Admission and ID Consult

  40. Specific Therapy OrganismAntibioticDuration S. pneumoniae MIC PCN <0.1 Penicillin G or Ampicillin 10 – 14 days MIC PCN 0.1-1.0 3rd Gen Cephalosporin MIC PCN > 2 Vancomycin (MIC Ceph >1.0) plus 3rd Gen Cephalosporin (Rifampin) N. meningitidis MIC <0.1 Penicillin G, Ampicillin 7 days MIC 0.1-1.0 3rd Gen Cephalosporin H. Influenzae Sensitive Ampicillin 7 - 10 days Resistant 3rd Gen Cephalosporin Tunkel AR. IDSA Guidelines Meningitis. CID 2004;39:1267.

  41. Specific Therapy OrganismAntibioticDuration Gram-Negative 3rd Gen Cephalosporin 21 days or Enteric Organisms plus Aminoglycoside 14 days after Negative Pseudomonas Ceftazidime, Carbapenem, Ticarcillin, Piperacillin plus Aminoglycoside S. aureus Meth Sensitive Nafcillin or Oxacillin 21 days Meth Resistant Vancomycin and Rifampin Enterococcus Sensitive Ampicillin plus Aminoglycoside 14 – 21 days Amp Resistant Vancomycin plus Aminoglycoside Vanc Resistant Linezolid plus Aminoglycoside Tunkel AR. IDSA Guidelines Meningitis. CID 2004;39:1267.

  42. Neurosurgical ConditionOrganismAntibiotic Basilar Skull S. pneumoniae Vancomycin plus Fracture H. influenzae 3rd Gen Cephalosporin S. pyogenes Penetrating S. aureus, CoNS Vancomycin plus Cefepime, Trauma Gram-Neg Bacilli Ceftazidime, or Meropenem Postneurosurgery Gram-neg Bacilli Vancomycin plus Cefepime, S. aureus, CoNS Ceftazidime, or Meropenem CSF Shunt CoNS, S. aureus Vancomycin plus Cefepime, Gram-Neg Bacilli Ceftazidime, or Meropenem P. acnes Tunkel AR. IDSA Guidelines Meningitis. CID 2004;39:1267.

  43. Steroids • Dexamethasone • Decrease inflammatory mediators associated with worsening of morbidity and mortality (deafness and nerve damage) • Decrease penetration of antibiotics into the CSF (Vancomycin) • Mask fever and rebound fever after discontinuation • Recommendations (prior or with first dose of antibiotics) • Haemophilus influenzae beneficial effect (hearing loss) • S. pneumoniae possible effect - “For infants and children 6 weeks of age and older, adjunctive therapy with dexamethasone may be considered after weighing the potential benefits and possible risks.” • N. meningitidis no supporting data McIntyre PB, et al. JAMA 1997;278:925. AAP Committee on Infectious Diseases 2003. Tunkel AR, et al. CID 2004;39:1267.

  44. All S. pneumoniae were susceptible to penicillin Reduction in risk of an unfavorable outcome (RR, 0.59; 95% CI, 0.37 to 0.94; P=0.03) and mortality (RR of death, 0.48; 95% CI, 0.24 to 0.96; P=0.04) No beneficial effect on neurologic sequelae including focal neurologic abnormalities and hearing loss

  45. Chemoprophylaxis - Meningococus • High risk: Chemoprophylaxis recommended • Household contact, Child care or nursery school contact, Direct exposure to index patient’s secretions (kissing, toothbrushes, eating utensils), Mouth-to-mouth resuscitation, Unprotected contact during endotracheal intubation, Frequently slept or ate in same dwelling, Passengers seated directly next to the index case during airline flights lasting more than 8 hours • Low risk: Chemoprophylaxis not recommended • Casual contact: No history of direct exposure to index patient’s oral secretions (eg, school or work), Indirect contact - only contact is with a high-risk contact, Health care professionals without direct exposure to patient’s oral secretions • In Outbreak or cluster • Chemoprophylaxis for people other than people at high risk should be administered only after consultation with local public health authorities Red Book 27th Ed. 2006.

  46. Chemoprophylaxis - Meningococcus Age DoseDurationEfficacy Rifampin < 1 mo 5 mg/kg q12 2 days >1 mo 10 mg/kg q12 2 days 90-95% (max 600 mg) Ceftriaxone < 15 yo 125 mg Single dose 90-95% > 15 yo 250 mg Single dose 90-95% Ciprofloxacin >18 yo 500 mg Single dose 90-95% Red Book 27th Ed. 2006.

  47. Chemoprophylaxis – Haemophilus • High risk: Chemoprophylaxis recommended • For all household contact in the following circumstances: Household with at least 1 contact < 4 years of age who is unimmunized or incompletely immunized, Household with a child < 12 months of age who has not received the primary series, Household with a contact who is an immunocompromised child, regardless of that child’s Hib immunization status • For nursery school and child care center contacts when 2 or more cases of Hib invasive disease have occurred within 60 days • Chemoprophylaxis not recommended • For occupants of households with no children < 4 years of age • For occupants of households when all household contacts 12 to 48 months of age have completed their Hib immunization series and when household contacts < 12 months have completed their primary series of Hib immunizations • For nursery school and child care contacts of 1 index case • For pregnant women Red Book 27th Ed. 2006.

  48. Meningococcal Vaccines Menactra (MCV4) Licensed in 2005 11 – 55 years old Protection at least 10 years Recommendations: High-risk groups (>10 years old) 11- to 12-year visit High-school entry or 15 years old College students living in dorms Menomune (MPSV4) Licensed in 1981 > 2 years old Protection 3 – 5 years Recommendations: High-risk groups (2 – 10 yrs old) - Functional or anatomic asplenia - Terminal C’ or properdin deficient - Travel to areas where Meningococcus is epidemic A, C, Y, W-135 Red Book 2006

  49. Swartz MN. NEJM 2004;351:18.

  50. Prognosis • Mortality rate (4 – 10%) • Infants and Children < 5 % • Streptococcus pneumoniae 10 % • Neisseria meningitis 3 – 5 % • Haemophilus influenzae 3 – 5 % • Factors associated with a poor outcome • Extremes of age • Hypotension • Altered mental status • Seizures • S. pneumoniae, GBBS, Gram-negative bacilli • High bacterial burden • Delayed sterilization of CSF • Low CSF glucose (<20 mg/dL) Chavez-Bueno S. Pediatr Clin N Amer 2005;52:795.

More Related